AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2024
Oct 7, 2024
35124_dirs_2024-10-07_8080549f-1882-4147-a38b-e3f74f870d8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2024-10-07
Reporting Person: Eylward Susan (General Counsel and Corp Sec)
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18